vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. It offers Azeliragon, TTP399, TTP273, HPP593, HPP737, and the Nrf2/Bach1 program. The company was founded on April 2, 2015 and is headquartered in High Point, NC.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
23
Frequently Asked Questions
What is Market Cap of vTv Therapeutics Inc - Ordinary Shares - Class A?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. vTv Therapeutics Inc - Ordinary Shares - Class A market cap is $52.5M.
What is the 52-week high for vTv Therapeutics Inc - Ordinary Shares - Class A?
52 week high is the highest price of a stock in the past 52 weeks, or one year. vTv Therapeutics Inc - Ordinary Shares - Class A 52 week high is $26.99 as of September 12, 2025.
What is the 52-week low for vTv Therapeutics Inc - Ordinary Shares - Class A?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. vTv Therapeutics Inc - Ordinary Shares - Class A 52 week low is $12.62 as of September 12, 2025.
What is vTv Therapeutics Inc - Ordinary Shares - Class A stock price today?
vTv Therapeutics Inc - Ordinary Shares - Class A stock price today is $19.93.
What was vTv Therapeutics Inc - Ordinary Shares - Class A stock price yesterday?
vTv Therapeutics Inc - Ordinary Shares - Class A stock price yesterday was $20.06.
What is the PE ratio of vTv Therapeutics Inc - Ordinary Shares - Class A?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. vTv Therapeutics Inc - Ordinary Shares - Class A’s P/E ratio is -6.43.
What is the Price-to-Book ratio of vTv Therapeutics Inc - Ordinary Shares - Class A?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. vTv Therapeutics Inc - Ordinary Shares - Class A P/B ratio is 19.0085.
What is the 50-day moving average of vTv Therapeutics Inc - Ordinary Shares - Class A?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. vTv Therapeutics Inc - Ordinary Shares - Class A 50-day moving average is $16.18.
How many employess does vTv Therapeutics Inc - Ordinary Shares - Class A has?
vTv Therapeutics Inc - Ordinary Shares - Class A has 23 employees.
